A carregar...
ANGI-09. CIRCULATING MIR-10B AND MIR-21 IN PATIENTS WITH GBM TREATED WITH BEVACIZUMAB ARE SECRETED TO THE CIRCULATION BY PROTEINS AND THEIR HIGH QUANTIFICATION IS PROBABLY THE RESULT OF DRUG-INDUCED TUMOR HYPOXIA
Bevacizumab is a one of the salvage therapy to patients with recurrent GBM. Antiangiogenic treatment such bevacizumab reduce blood supply and consequently increase hypoxia in the tumor microenvironment. We previously demonstrated that miR-10b and miR-21 are highly quantified in the circulation follo...
Na minha lista:
| Publicado no: | Neuro Oncol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6217044/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.110 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|